Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pharmacokinetics of MDV3100 × Pioglitazone × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Insulin Resistance 3 Urinary Bladder Neoplasms 2 Diabetes Mellitus, Type 2 2 Prostatic Neoplasms, Castration-Resistant 1 Pharmacokinetics of MDV3100 1 Diabetes Mellitus 1

Interventions

enzalutamide 1 Warfarin 1 Pioglitazone 1 Omeprazole 1 Midazolam 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01911728 2017-06-26

Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates

Astellas Pharma Inc

Phase 1 Completed

Pharmacokinetics of MDV3100

Data powered by HemOnc (CC BY 4.0) Colophon ⚡